URBINATI, Chiara Eva
URBINATI, Chiara Eva
Dipartimento di Scienze Cliniche e Sperimentali
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells
1996-01-01 Rusnati, Marco; Dell'Era, Patrizia; Urbinati, Chiara Eva; Tanghetti, Elena; Massardi, Ml; Nagamine, Y; Monti, Eugenio; Presta, Marco
Activation of endothelial cell mitogen activated protein kinase ERK 1/2 by extracellular HIV-1 Tat protein
2001-01-01 Rusnati, Marco; Urbinati, Chiara Eva; Musulin, B.; Ribatti, D.; Albini, A.; Noonan, D.; Marchisone, C.; Waltenberger, J.; Presta, Marco
alpha v beta 3 integrin-dependent activation of focal adhesion kinase mediates NF-kB activation and motogenic activity by HIV-1 Tat in endothelial cells
2005-01-01 Urbinati, Chiara Eva; Bugatti, Antonella; M., Giacca; D., Schlaepfer; Presta, Marco; Rusnati, Marco
An innovative strategy to investigate microbial protein modifications in a reliable fast and sensitive way: A therapy oriented proof of concept based on UV-C irradiation of SARS-CoV-2 spike protein
2023-01-01 Strizzi, Sergio; Bernardo, Letizia; D'Ursi, Pasqualina; Urbinati, Chiara; Bianco, Andrea; Limanaqi, Fiona; Manconi, Andrea; Milanesi, Maria; Macchi, Alberto; Di Silvestre, Dario; Cavalleri, Adalberto; Pareschi, Giovanni; Rusnati, Marco; Clerici, Mario; Mauri, Pierluigi; Biasin, Mara
Angiogenic growth factor-endothelial cell interaction: receptor binding and cell internalization techniques
2003-01-01 Urbinati, Chiara Eva; L., Tassone; Bugatti, Antonella; M., Camozzi; Rusnati, Marco
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists.
2005-01-01 Presta, Marco; Oreste, P; Zoppetti, G; Belleri, Mirella; Tanghetti, Elena; Leali, D; Urbinati, Chiara Eva; Bugatti, Antonella; Ronca, Roberto; Nicoli, S; Moroni, Emanuela; Stabile, H; Camozzi, Maura; Hernandez, Ga; Mitola, Stefania Maria Filomena; Dell'Era, Patrizia; Rusnati, Marco; Ribatti, D.
Basic fibroblast growth factor and endothelial cells: receptor interaction, signal trasduction, cellular response. Dissociation of the mitogenic activity of bFGF from its plasminigen activator-inducing activity
1992-01-01 Presta, Marco; Rusnati, Marco; J. A. M., Maier; Urbinati, Chiara Eva; M., Statuto; A., Gualandris; A., Pozzi; G., Ragnotti
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts.
2002-01-01 Tanghetti, Elena; R., Ria; Dell'Era, Patrizia; Urbinati, Chiara Eva; Rusnati, Marco; M. G., Ennas; Presta, Marco
Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells.
1991-01-01 Presta, Marco; Rusnati, Marco; Urbinati, Chiara Eva; A., Sommer; G., Ragnotti
Bridging the past and the future of virology: Surface plasmon resonance as a powerful tool to investigate virus/host interactions.
2015-01-01 Rusnati, Marco; Chiodelli, Paola; Bugatti, Antonella; Urbinati, Chiara Eva
Cell membrane GM1 ganglioside is a functional co-receptor for Fibroblast growth factor-2.
2002-01-01 Rusnati, Marco; Urbinati, Chiara Eva; Tanghetti, Elena; Dell'Era, Patrizia; LORTAT JACOB, H; Presta, Marco
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists.
2004-01-01 Urbinati, Chiara Eva; Bugatti, Antonella; P., Oreste; G., Zoppetti; J., Waltenberger; Mitola, Stefania Maria Filomena; D., Ribatti; Presta, Marco; Rusnati, Marco
Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin
2021-01-01 Rusnati, M.; Paiardi, G.; Tobia, C.; Urbinati, C.; Lodola, A.; D'Ursi, P.; Corrado, M.; Castelli, R.; Wade, R. C.; Tognolini, M.; Chiodelli, P.
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis
2017-01-01 Chiodelli, Paola; Rezzola, Sara; Urbinati, Chiara Eva; FEDERICI SIGNORI, Federica; Monti, Eugenio; Ronca, Roberto; Presta, Marco; Rusnati, Marco
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine.
2006-01-01 Mitola, Stefania Maria Filomena; Belleri, Mirella; Urbinati, Chiara Eva; Coltrini, Daniela; Sparatore, B; Pedrazzi, M; Melloni, E; Presta, Marco
Cutting edge: proangiogenic properties of alternatively activated dendritic cells.
2005-01-01 Riboldi, Elena; T., Musso; Moroni, Emanuela; Urbinati, Chiara Eva; S., Bernasconi; Rusnati, Marco; L., Adorini; Presta, Marco; Sozzani, Silvano
Design, synthesis and biological evaluation of novel 2,4-thiazolidinedione derivatives able to target the human BAG3 protein
2023-01-01 Budassi, Federica; Marchioro, Chiara; Canton, Martina; Favaro, Annagiulia; Sturlese, Mattia; Urbinati, Chiara; Rusnati, Marco; Romagnoli, Romeo; Viola, Giampietro; Mariotto, Elena
Discovery of novel VX-809 hybrid derivatives as F508del-CFTR correctors by molecular modeling, chemical synthesis and biological assays
2020-01-01 Parodi, A.; Righetti, G.; Pesce, E.; Salis, A.; Tasso, B.; Urbinati, C.; Tomati, V.; Damonte, G.; Rusnati, M.; Pedemonte, N.; Cichero, E.; Millo, E.
Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorionallantoic membranes
1995-01-01 D., Ribatti; Urbinati, Chiara Eva; B., Nico; Rusnati, Marco; L., Roncali; Presta, Marco
endothelial cell adhesion to HIV-1 Tat: cross talk between integrin alphav beta3 and vascular endothelial growth factor receptor-2 (KDR)
2007-01-01 Urbinati, Chiara Eva; Ravelli, Cosetta; Bugatti, Antonella; Presta, Marco; Rusnati, Marco
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells | 1-gen-1996 | Rusnati, Marco; Dell'Era, Patrizia; Urbinati, Chiara Eva; Tanghetti, Elena; Massardi, Ml; Nagamine, Y; Monti, Eugenio; Presta, Marco | |
| Activation of endothelial cell mitogen activated protein kinase ERK 1/2 by extracellular HIV-1 Tat protein | 1-gen-2001 | Rusnati, Marco; Urbinati, Chiara Eva; Musulin, B.; Ribatti, D.; Albini, A.; Noonan, D.; Marchisone, C.; Waltenberger, J.; Presta, Marco | |
| alpha v beta 3 integrin-dependent activation of focal adhesion kinase mediates NF-kB activation and motogenic activity by HIV-1 Tat in endothelial cells | 1-gen-2005 | Urbinati, Chiara Eva; Bugatti, Antonella; M., Giacca; D., Schlaepfer; Presta, Marco; Rusnati, Marco | |
| An innovative strategy to investigate microbial protein modifications in a reliable fast and sensitive way: A therapy oriented proof of concept based on UV-C irradiation of SARS-CoV-2 spike protein | 1-gen-2023 | Strizzi, Sergio; Bernardo, Letizia; D'Ursi, Pasqualina; Urbinati, Chiara; Bianco, Andrea; Limanaqi, Fiona; Manconi, Andrea; Milanesi, Maria; Macchi, Alberto; Di Silvestre, Dario; Cavalleri, Adalberto; Pareschi, Giovanni; Rusnati, Marco; Clerici, Mario; Mauri, Pierluigi; Biasin, Mara | |
| Angiogenic growth factor-endothelial cell interaction: receptor binding and cell internalization techniques | 1-gen-2003 | Urbinati, Chiara Eva; L., Tassone; Bugatti, Antonella; M., Camozzi; Rusnati, Marco | |
| Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. | 1-gen-2005 | Presta, Marco; Oreste, P; Zoppetti, G; Belleri, Mirella; Tanghetti, Elena; Leali, D; Urbinati, Chiara Eva; Bugatti, Antonella; Ronca, Roberto; Nicoli, S; Moroni, Emanuela; Stabile, H; Camozzi, Maura; Hernandez, Ga; Mitola, Stefania Maria Filomena; Dell'Era, Patrizia; Rusnati, Marco; Ribatti, D. | |
| Basic fibroblast growth factor and endothelial cells: receptor interaction, signal trasduction, cellular response. Dissociation of the mitogenic activity of bFGF from its plasminigen activator-inducing activity | 1-gen-1992 | Presta, Marco; Rusnati, Marco; J. A. M., Maier; Urbinati, Chiara Eva; M., Statuto; A., Gualandris; A., Pozzi; G., Ragnotti | |
| Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. | 1-gen-2002 | Tanghetti, Elena; R., Ria; Dell'Era, Patrizia; Urbinati, Chiara Eva; Rusnati, Marco; M. G., Ennas; Presta, Marco | |
| Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. | 1-gen-1991 | Presta, Marco; Rusnati, Marco; Urbinati, Chiara Eva; A., Sommer; G., Ragnotti | |
| Bridging the past and the future of virology: Surface plasmon resonance as a powerful tool to investigate virus/host interactions. | 1-gen-2015 | Rusnati, Marco; Chiodelli, Paola; Bugatti, Antonella; Urbinati, Chiara Eva | |
| Cell membrane GM1 ganglioside is a functional co-receptor for Fibroblast growth factor-2. | 1-gen-2002 | Rusnati, Marco; Urbinati, Chiara Eva; Tanghetti, Elena; Dell'Era, Patrizia; LORTAT JACOB, H; Presta, Marco | |
| Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. | 1-gen-2004 | Urbinati, Chiara Eva; Bugatti, Antonella; P., Oreste; G., Zoppetti; J., Waltenberger; Mitola, Stefania Maria Filomena; D., Ribatti; Presta, Marco; Rusnati, Marco | |
| Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin | 1-gen-2021 | Rusnati, M.; Paiardi, G.; Tobia, C.; Urbinati, C.; Lodola, A.; D'Ursi, P.; Corrado, M.; Castelli, R.; Wade, R. C.; Tognolini, M.; Chiodelli, P. | |
| Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis | 1-gen-2017 | Chiodelli, Paola; Rezzola, Sara; Urbinati, Chiara Eva; FEDERICI SIGNORI, Federica; Monti, Eugenio; Ronca, Roberto; Presta, Marco; Rusnati, Marco | |
| Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. | 1-gen-2006 | Mitola, Stefania Maria Filomena; Belleri, Mirella; Urbinati, Chiara Eva; Coltrini, Daniela; Sparatore, B; Pedrazzi, M; Melloni, E; Presta, Marco | |
| Cutting edge: proangiogenic properties of alternatively activated dendritic cells. | 1-gen-2005 | Riboldi, Elena; T., Musso; Moroni, Emanuela; Urbinati, Chiara Eva; S., Bernasconi; Rusnati, Marco; L., Adorini; Presta, Marco; Sozzani, Silvano | |
| Design, synthesis and biological evaluation of novel 2,4-thiazolidinedione derivatives able to target the human BAG3 protein | 1-gen-2023 | Budassi, Federica; Marchioro, Chiara; Canton, Martina; Favaro, Annagiulia; Sturlese, Mattia; Urbinati, Chiara; Rusnati, Marco; Romagnoli, Romeo; Viola, Giampietro; Mariotto, Elena | |
| Discovery of novel VX-809 hybrid derivatives as F508del-CFTR correctors by molecular modeling, chemical synthesis and biological assays | 1-gen-2020 | Parodi, A.; Righetti, G.; Pesce, E.; Salis, A.; Tasso, B.; Urbinati, C.; Tomati, V.; Damonte, G.; Rusnati, M.; Pedemonte, N.; Cichero, E.; Millo, E. | |
| Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorionallantoic membranes | 1-gen-1995 | D., Ribatti; Urbinati, Chiara Eva; B., Nico; Rusnati, Marco; L., Roncali; Presta, Marco | |
| endothelial cell adhesion to HIV-1 Tat: cross talk between integrin alphav beta3 and vascular endothelial growth factor receptor-2 (KDR) | 1-gen-2007 | Urbinati, Chiara Eva; Ravelli, Cosetta; Bugatti, Antonella; Presta, Marco; Rusnati, Marco |